Aligos Therapeutics, Inc. (ALGS)
5.34
+0.03
(+0.56%)
USD |
NASDAQ |
Oct 09, 16:00
5.32
-0.02
(-0.37%)
After-Hours: 20:00
Aligos Therapeutics Price : 5.34 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 5.27 | 5.442 | 5.27 | 5.34 | 9059.00 |
| Oct 08, 2026 | 5.25 | 5.53 | 5.08 | 5.31 | 37365.00 |
| Oct 07, 2026 | 5.33 | 5.525 | 5.230 | 5.32 | 19405.00 |
| Oct 06, 2026 | 5.46 | 5.53 | 5.310 | 5.38 | 12842.00 |
| Oct 05, 2026 | 5.57 | 5.65 | 5.35 | 5.40 | 48609.00 |
| Oct 02, 2026 | 5.58 | 5.72 | 5.37 | 5.54 | 29035.00 |
| Oct 01, 2026 | 5.69 | 5.74 | 5.367 | 5.50 | 28258.00 |
| Sep 30, 2026 | 5.65 | 5.80 | 5.54 | 5.63 | 35330.00 |
| Sep 29, 2026 | 5.53 | 5.68 | 5.40 | 5.62 | 11487.00 |
| Sep 28, 2026 | 5.38 | 5.54 | 5.18 | 5.54 | 79519.00 |
| Sep 25, 2026 | 5.70 | 5.765 | 5.47 | 5.51 | 45047.00 |
| Sep 24, 2026 | 5.55 | 5.695 | 5.27 | 5.55 | 59869.00 |
| Sep 23, 2026 | 5.72 | 5.936 | 5.45 | 5.56 | 35074.00 |
| Sep 22, 2026 | 5.57 | 6.30 | 5.222 | 5.68 | 75687.00 |
| Sep 21, 2026 | 5.31 | 5.88 | 5.21 | 5.49 | 125046.0 |
| Sep 18, 2026 | 5.15 | 5.25 | 5.015 | 5.24 | 21341.00 |
| Sep 17, 2026 | 5.10 | 5.29 | 5.10 | 5.17 | 21705.00 |
| Sep 16, 2026 | 5.01 | 5.13 | 4.93 | 5.05 | 41652.00 |
| Sep 15, 2026 | 5.04 | 5.445 | 4.82 | 4.99 | 34487.00 |
| Sep 14, 2026 | 5.17 | 5.27 | 5.02 | 5.04 | 28021.00 |
| Sep 11, 2026 | 5.39 | 5.502 | 5.14 | 5.22 | 37044.00 |
| Sep 10, 2026 | 5.38 | 5.48 | 5.21 | 5.33 | 46072.00 |
| Sep 09, 2026 | 5.79 | 6.02 | 5.410 | 5.50 | 33016.00 |
| Sep 08, 2026 | 6.21 | 6.340 | 5.62 | 5.76 | 64235.00 |
| Sep 04, 2026 | 6.16 | 6.21 | 6.02 | 6.21 | 20289.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 414.87 |
| Anika Therapeutics, Inc. | 19.58 |
| BioCryst Pharmaceuticals, Inc. | 8.55 |
| Imunon, Inc. | 1.08 |
Price Related Metrics
| PS Ratio | 1.762 |
| Price to Book Value | 1.045 |
| Earnings Yield | -137.0% |
| Market Cap | 33.30M |